• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

March 25, 2019

View Archived Issues

BioInvent discloses a program to target TNFR2 for the treatment of solid tumors

Read More

VLP Therapeutics initiates phase I study of VLPM-01 vaccine

Read More

Lead Pharma initiates phase I study of SAR-441169

Read More

Insight into the metabolic-epigenetic interplay of fumaric acid esters in brain-homing T cells in MS

Read More

Ahammune Biosciences discloses compounds for celiac disease

Read More

NLRP3 inflammasome inhibitors synthesized at Cadila Healthcare

Read More

Kappa-opioid receptor agonists patented by University of Tsukuba, Nippon Chemiphar

Read More

Shanghai Meizer Pharmaceuticals identifies new Bruton tyrosine kinase inhibitors

Read More

Orion, Gedeon Richter describe D-amino-acid oxidase inhibitors

Read More

Toray Industries discovers nuclear receptor ROR-gamma antagonists

Read More

Gene editing success in blood stem cells

Read More

Phase II safety data for nivolumab in combination with ipilimumab in metastatic uveal melanoma

Read More

BKM-1972 inhibits intraosseous growth of chemosensitive and chemoresistant prostate cancer

Read More

Aberrant SATB2 expression as a novel biomarker of IBD-associated colorectal neoplasia

Read More

Data for [177Lu]PP-F11N presented for medullary thyroid carcinoma

Read More

TIA1 shows a physiological and partly sex-dependent role in avoidance behavior and fear memory

Read More

Blood needs Prozac, too

Read More

Autosomal myopathy protein compensates for X-linked form

Read More

Oncolytic reovirus is active against castration-resistant prostate cancer

Read More

European Commission approves Forxiga for type 1 diabetes

Read More

FDA issues second complete response letter for Recro's intravenous meloxicam

Read More

UGRP1 for differential diagnosis of Hashimoto's hyperthyroidism among patients with Graves' disease

Read More

Ovoca reports phase III data on Libicore for women with hypoactive sexual desire disorder

Read More

Phase II trial of SFX-01 in metastatic breast cancer meets primary endpoints

Read More

Arvinas initiates phase I study of ARV-110 in metastatic castration-resistant prostate cancer

Read More

Proteostasis reports data set on CFTR modulator triple combination therapy

Read More

FDA issues complete response letter for Zynquista for type 1 diabetes

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe